BioHorizons Tapered IM Implants— 510(k) K182070

Name: FDA 510(k) clearance K182070
Creator: U.S. Food and Drug Administration
Published: 2018-10-10

Substantially Equivalent

BioHorizons Implant Systems, Inc.

FDA 510(k) clearance K182070 for BioHorizons Tapered IM Implants, Substantially Equivalent on 2018-10-10. Applicant: BioHorizons Implant Systems, Inc.. Device class: 2.

Clearance details

Applicant: BioHorizons Implant Systems, Inc.
Product code: Code DZE
Device class: Class 2
Regulation: 21 CFR 872.3640
Advisory panel: Dental
Date received: 2018-08-01
Decision date: 2018-10-10
Decision: Substantially Equivalent
Clearance type: Special
Location: Birmingham, AL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DZE

view all

K260463 — ZEROS Dental Implant System2026-08-19
K251188 — UNIQA® Dental Implants System2026-06-25
K250806 — Dental Implant System2026-06-18
K251232 — MegaGen Zygoma Dental Implant System2026-06-18
K260006 — INOSS System2026-06-17

More clearances from BioHorizons Implant Systems, Inc.

view all

K260061 — BioHorizons CEREC Compatible Ti-Bases2026-06-26
K243521 — Conical Ti Base abutments2025-05-01
K240531 — SmartShape Healing Abutment; Wide Custom Milled Ti-Blank Abutment2024-07-30
K240187 — Tapered Pro Conical Implant System2024-06-05
K223697 — MRI compatibility for existing BioHorizons dental implants and abutments2023-10-13

Adverse events under product code DZE

product code DZE

Death: 28
Injury: 3,367,041
Malfunction: 19,958
Other: 13
Total: 3,387,040

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.